Carducci MA - Search Results

1

The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer.

Paller CJ, Olatoye D, Xie S, Zhou X, Denmeade SR, Eisenberger MA, Antonarakis ES, Carducci MA, Rosner GL. Paller CJ, et al. Among authors: carducci ma. Prostate Cancer Prostatic Dis. 2014 Mar;17(1):28-33. doi: 10.1038/pcan.2013.40. Epub 2013 Oct 8. Prostate Cancer Prostatic Dis. 2014. PMID: 24100642 Free PMC article.

2

Interleukin-6: a candidate mediator of human prostate cancer morbidity.

Twillie DA, Eisenberger MA, Carducci MA, Hseih WS, Kim WY, Simons JW. Twillie DA, et al. Among authors: carducci ma. Urology. 1995 Mar;45(3):542-9. doi: 10.1016/S0090-4295(99)80034-X. Urology. 1995. PMID: 7879350

3

Prostate cancer treatment strategies based on tumor-specific biological principles: future directions.

Carducci MA, DeWeese TL, Nelson WG, Simons JW, Sinibaldi V, Eisenberger MA. Carducci MA, et al. Semin Oncol. 1996 Dec;23(6 Suppl 14):56-62. Semin Oncol. 1996. PMID: 8996587 Review.

4

Prostate-specific antigen and other markers of therapeutic response.

Carducci MA, DeWeese TL, Nelson JB. Carducci MA, et al. Urol Clin North Am. 1999 May;26(2):291-302, viii. doi: 10.1016/s0094-0143(05)70069-0. Urol Clin North Am. 1999. PMID: 10361552 Free article. Review.

5

Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group.

Bubley GJ, Carducci M, Dahut W, Dawson N, Daliani D, Eisenberger M, Figg WD, Freidlin B, Halabi S, Hudes G, Hussain M, Kaplan R, Myers C, Oh W, Petrylak DP, Reed E, Roth B, Sartor O, Scher H, Simons J, Sinibaldi V, Small EJ, Smith MR, Trump DL, Wilding G, et al. Bubley GJ, et al. J Clin Oncol. 1999 Nov;17(11):3461-7. doi: 10.1200/JCO.1999.17.11.3461. J Clin Oncol. 1999. PMID: 10550143

6

Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer.

Sinibaldi VJ, Carducci M, Laufer M, Eisenberger M. Sinibaldi VJ, et al. Semin Oncol. 1999 Oct;26(5 Suppl 17):45-8. Semin Oncol. 1999. PMID: 10604269 Clinical Trial.

7

Management of patients with rising prostate-specific antigen after radical prostatectomy.

Laufer M, Pound CR, Carducci MA, Eisenberger MA. Laufer M, et al. Among authors: carducci ma. Urology. 2000 Mar;55(3):309-15. doi: 10.1016/s0090-4295(99)00465-3. Urology. 2000. PMID: 10699599 Review. No abstract available.

8

Rapid disease progression after the administration of bicalutamide in patients with metastatic prostate cancer.

Laufer M, Sinibaldi VJ, Carducci MA, Eisenberger MA. Laufer M, et al. Among authors: carducci ma. Urology. 1999 Oct;54(4):745. doi: 10.1016/s0090-4295(99)00268-x. Urology. 1999. PMID: 10754148 Free article.

9

Complete androgen blockade for prostate cancer: what went wrong?

Laufer M, Denmeade SR, Sinibaldi VJ, Carducci MA, Eisenberger MA. Laufer M, et al. Among authors: carducci ma. J Urol. 2000 Jul;164(1):3-9. J Urol. 2000. PMID: 10840412 Free article. Review.

10

Identification and characterization of circulating prostate carcinoma cells.

Wang ZP, Eisenberger MA, Carducci MA, Partin AW, Scher HI, Ts'o PO. Wang ZP, et al. Among authors: carducci ma. Cancer. 2000 Jun 15;88(12):2787-95. doi: 10.1002/1097-0142(20000615)88:12<2787::aid-cncr18>3.0.co;2-2. Cancer. 2000. PMID: 10870062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters